Dr. Tom Sheidow is an associate professor in the Department of Ophthalmology at Western University, London, Canada. Dr Sheidow’s major clinical and research interests are in age-related macular degeneration (AMD) and macular diseases; he has been a participant in many of the major AMD and diabetes clinical trials over recent years. He was co-chair for the Canadian trials evaluating Lucentis vs Laser for Diabetic Macular Edema (RESPOND) and the use of the Treat-and-Extend Regimen for Lucentis in AMD (CanTREAT). Dr. Sheidow’s current areas of interest are AMD and teleophthalmology and its application to patient screening and referral. Dr Sheidow is a fellow and diplomat of the RCPSC, a member of the Canadian Ophthalmology Society and is the current retina section editor for the Canadian Journal of Ophthalmology.
